Stock listing

Spyre Therapeutics, Inc.

Selected listing: SYRE · NASDAQ · USD · US

Spyre Therapeutics, Inc. (NASDAQ:SYRE), Health Technology. Latest release Oct 5, 2026: Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

SYRE:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:SYRE
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. is a public company traded under the ticker SYRE in the American market. The company is dedicated to advancing healthcare solutions to improve patient outcomes.

Latest news from Spyre Therapeutics, Inc.

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

October 5, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

October 4, 2026

Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

October 4, 2026

Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

October 4, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

October 2, 2026

All Spyre Therapeutics, Inc. news →

Research Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. company profile

View the public company page for Spyre Therapeutics, Inc. on 6ix.

Spyre Therapeutics, Inc. news

Read company news and market updates connected to Spyre Therapeutics, Inc..

Spyre Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Spyre Therapeutics, Inc..